Cargando…

Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study

OBJECTIVES: The purpose of this study is to evaluate the predictive value of the amount of fibroglandular tissue (FGT) and background parenchymal enhancement (BPE), measured at baseline on breast MRI, for breast cancer development and risk of false-positive findings in women at increased risk for br...

Descripción completa

Detalles Bibliográficos
Autores principales: Vreemann, Suzan, Dalmis, Mehmet U., Bult, Peter, Karssemeijer, Nico, Broeders, Mireille J. M., Gubern-Mérida, Albert, Mann, Ritse M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682856/
https://www.ncbi.nlm.nih.gov/pubmed/30796568
http://dx.doi.org/10.1007/s00330-019-06020-2
_version_ 1783441962056024064
author Vreemann, Suzan
Dalmis, Mehmet U.
Bult, Peter
Karssemeijer, Nico
Broeders, Mireille J. M.
Gubern-Mérida, Albert
Mann, Ritse M.
author_facet Vreemann, Suzan
Dalmis, Mehmet U.
Bult, Peter
Karssemeijer, Nico
Broeders, Mireille J. M.
Gubern-Mérida, Albert
Mann, Ritse M.
author_sort Vreemann, Suzan
collection PubMed
description OBJECTIVES: The purpose of this study is to evaluate the predictive value of the amount of fibroglandular tissue (FGT) and background parenchymal enhancement (BPE), measured at baseline on breast MRI, for breast cancer development and risk of false-positive findings in women at increased risk for breast cancer. METHODS: Negative baseline MRI scans of 1533 women participating in a screening program for women at increased risk for breast cancer between January 1, 2003, and January 1, 2014, were selected. Automated tools based on deep learning were used to obtain quantitative measures of FGT and BPE. Logistic regression using forward selection was used to assess relationships between FGT, BPE, cancer detection, false-positive recall, and false-positive biopsy. RESULTS: Sixty cancers were detected in follow-up. FGT was only associated to short-term cancer risk; BPE was not associated with cancer risk. High FGT and BPE did lead to more false-positive recalls at baseline (OR 1.259, p = 0.050, and OR 1.475, p = 0.003) and to more frequent false-positive biopsies at baseline (OR 1.315, p = 0.049, and OR 1.807, p = 0.002), but were not predictive for false-positive findings in subsequent screening rounds. CONCLUSIONS: FGT and BPE, measured on baseline MRI, are not predictive for overall breast cancer development in women at increased risk. High FGT and BPE lead to more false-positive findings at baseline. KEY POINTS: • Amount of fibroglandular tissue is only predictive for short-term breast cancer risk in women at increased risk. • Background parenchymal enhancement measured on baseline MRI is not predictive for breast cancer development in women at increased risk. • High amount of fibroglandular tissue and background parenchymal enhancement lead to more false-positive findings at baseline MRI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06020-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6682856
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-66828562019-08-19 Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study Vreemann, Suzan Dalmis, Mehmet U. Bult, Peter Karssemeijer, Nico Broeders, Mireille J. M. Gubern-Mérida, Albert Mann, Ritse M. Eur Radiol Magnetic Resonance OBJECTIVES: The purpose of this study is to evaluate the predictive value of the amount of fibroglandular tissue (FGT) and background parenchymal enhancement (BPE), measured at baseline on breast MRI, for breast cancer development and risk of false-positive findings in women at increased risk for breast cancer. METHODS: Negative baseline MRI scans of 1533 women participating in a screening program for women at increased risk for breast cancer between January 1, 2003, and January 1, 2014, were selected. Automated tools based on deep learning were used to obtain quantitative measures of FGT and BPE. Logistic regression using forward selection was used to assess relationships between FGT, BPE, cancer detection, false-positive recall, and false-positive biopsy. RESULTS: Sixty cancers were detected in follow-up. FGT was only associated to short-term cancer risk; BPE was not associated with cancer risk. High FGT and BPE did lead to more false-positive recalls at baseline (OR 1.259, p = 0.050, and OR 1.475, p = 0.003) and to more frequent false-positive biopsies at baseline (OR 1.315, p = 0.049, and OR 1.807, p = 0.002), but were not predictive for false-positive findings in subsequent screening rounds. CONCLUSIONS: FGT and BPE, measured on baseline MRI, are not predictive for overall breast cancer development in women at increased risk. High FGT and BPE lead to more false-positive findings at baseline. KEY POINTS: • Amount of fibroglandular tissue is only predictive for short-term breast cancer risk in women at increased risk. • Background parenchymal enhancement measured on baseline MRI is not predictive for breast cancer development in women at increased risk. • High amount of fibroglandular tissue and background parenchymal enhancement lead to more false-positive findings at baseline MRI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06020-2) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-02-22 2019 /pmc/articles/PMC6682856/ /pubmed/30796568 http://dx.doi.org/10.1007/s00330-019-06020-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Magnetic Resonance
Vreemann, Suzan
Dalmis, Mehmet U.
Bult, Peter
Karssemeijer, Nico
Broeders, Mireille J. M.
Gubern-Mérida, Albert
Mann, Ritse M.
Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title_full Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title_fullStr Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title_full_unstemmed Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title_short Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study
title_sort amount of fibroglandular tissue fgt and background parenchymal enhancement bpe in relation to breast cancer risk and false positives in a breast mri screening program: a retrospective cohort study
topic Magnetic Resonance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682856/
https://www.ncbi.nlm.nih.gov/pubmed/30796568
http://dx.doi.org/10.1007/s00330-019-06020-2
work_keys_str_mv AT vreemannsuzan amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT dalmismehmetu amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT bultpeter amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT karssemeijernico amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT broedersmireillejm amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT gubernmeridaalbert amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy
AT mannritsem amountoffibroglandulartissuefgtandbackgroundparenchymalenhancementbpeinrelationtobreastcancerriskandfalsepositivesinabreastmriscreeningprogramaretrospectivecohortstudy